As explained by the National Kidney Foundation, the goal of management of chronic hyperkalemia -- i.e., high levels of potassium in the blood -- is to prevent the development or recurrence of the ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Today, the US Food and Drug Administration (FDA) approved a label update in the US for AstraZeneca’s LOKELMA® (sodium zirconium cyclosilicate) to include a dosing ...

Please provide your email address to receive an email when new articles are posted on . After a hyperkalemia event, mineralocorticoid receptor antagonists were discontinued in up to 46% of patients.

Credit: Shutterstock A committee of nephrologists and cardiologists developed 6 recommendations to improve hyperkalemia management. Patients with chronic kidney disease, heart failure, and diabetes ...

—European investigators examined pretransplant plasma potassium levels and the need for potassium-lowering interventions to resolve hyperkalemia within 48 hours after kidney transplantation. Chronic ...

Hyponatremia at Hemodialysis Initiation Increases Death Risk Nationally standardized treatment algorithms for hyperkalemia should be developed, according to investigators. The following article ...